← All stocks

LIGAND PHARMACEUTICALS INC

LGND Net selling
CIK 0000886163 #1265 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$35.00M
$2.17M on a plan · $27.83M straight out of an exercise
Sold at will
$5.00M
12 of 132 sales
Net
−$35.00M
−$5.00M against sales at will

By person

11 insiders · 140 transactions
78.4×

Todd C. Davis holds 78.4 times base salary in stock. $56.86M of shares against $724.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Todd C. Davis last reported holding, valued at $285.00, the price Common Stock was last bought or sold at on the open market here, on 10 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Espinoza Octavio
Chief Financial Officer
$13.03M (14) scheduled
−$13.03M
27,696
0.1389%
$7.89M
+5.9%
Reardon Andrew
CLO & Secretary
$8.77M (54) scheduled
−$8.77M
36,514
0.1832%
$10.41M
+68.6%
Haas Jason
Director
$3.74M (3) scheduled
−$3.74M
3,981
0.0200%
$1.13M
−26.2%
Aryeh Jason
Director
$2.96M (5)
−$2.96M
102,580
0.5146%
$29.24M
−9.6%
LAMATTINA JOHN L
Director
$2.44M (7) scheduled
−$2.44M
26,969
0.1353%
$7.69M
−8.6%
Gray Nancy Ryan
Director
$1.35M (2) scheduled
−$1.35M
8,930
0.0448%
$2.55M
+29.7%
KOZARICH JOHN W
Director
$1.20M (43) scheduled
−$1.20M
42,622
0.2138%
$12.15M
−2.6%
Sabba Stephen L
Director
$1.16M (3) scheduled
−$1.16M
33,629
0.1687%
$9.58M
+11.4%
Zimmermann Martine
Director
$342.00K (1)
−$342.00K
3,897
0.0195%
$1.11M
+10.2%
Davis Todd C
Chief Executive Officer
199,513
1.00%
$56.86M
+62.2%
Korenberg Matthew E
President & COO
50,777
0.2547%
$14.47M
−2.5%

Nothing of that kind in this period.

What was left out

Form 4 filings counted 52
Amendments (4/A) skipped 0
Filings about a different issuer 2
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 46
Sales straight out of an exercise 74
Sales at will 12
Transactions with no price 0
Shares from compensation/vesting 276,587
History held since 6 Sep 2016